ABNORMAL RECOMBINATION ACTIVATING GENE (RAG) AND IMMUNO DEFICIENCY

异常重组激活基因 (RAG) 和免疫缺陷

基本信息

项目摘要

1. Human Rag genomic locus ; Using a fragment of human RAG-1 cDNA, we isolated genomic DNA clones that contained either first or second exon of human RAG-1. We determined its exon/intron organization and the transcriptional start site. Similarly, we isolated genomic DNA clones that contains first or second exon of human RAG-2 and determined its exon/intron structure and the transcription initiation site for RAG-2. These led us to reveal, for the first time, the organization of human genomic RAG-1 and RAG-2 locus.2. Regulation of human RAG transcription ; We characterized promoter regions for human RAG-1 and RAG-2, and revealed that the 5' promoter region of RAG-lwas indispensable for its basal promoter activity. On the contrary, the sequences between -63 to -107 of RAG-2 were shown to be essential for its promoter acticity, suggesting the regulation of RAG-1 and RAG-2 transcription may be controled by different transcriptional mechanisms.3. Regulation of murine RAG-2 ; We found that the regulation of the mouse RAG-2 promoter activity is confered to 80 nucleotide upstream of RAG-2. We also found that a B cell-specific transcription protein, Pax-5, and a T cell-specific transcription protein, GATA-3, bind to the -80 to -17 nt region in B cells and T cells, respectively. These results indicate that distinct DNA binding proteins, Pax-5 and GATA-3, may regulate the murine RAG-2 promoter in B and T lineage cells, respectively.
1.人Rag基因座;使用人RAG-1 cDNA的片段,我们分离出包含人RAG-1的第一或第二外显子的基因组DNA克隆。我们确定了它的外显子/内含子组织和转录起始位点。同样地,我们分离了包含人RAG-2的第一或第二外显子的基因组DNA克隆,并确定了其外显子/内含子结构和RAG-2的转录起始位点。这些使我们首次揭示了人类基因组RAG-1和RAG-2位点的组织。人RAG转录的调控:我们鉴定了人RAG-1和RAG-2的启动子区域,并揭示了RAG-1的5 '启动子区域是其基础启动子活性所必需的。相反,RAG-2的-63~-107之间的序列是其启动子活性所必需的,提示RAG-1和RAG-2的转录调控可能受不同的转录机制控制.小鼠RAG-2的调节;我们发现小鼠RAG-2启动子活性的调节被赋予RAG-2上游80个核苷酸。我们还发现B细胞特异性转录蛋白Pax-5和T细胞特异性转录蛋白GATA-3分别与B细胞和T细胞中的-80至-17 nt区域结合。这些结果表明,不同的DNA结合蛋白,Pax-5和加塔-3,可以调节鼠RAG-2启动子在B和T谱系细胞,分别。

项目成果

期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsuda,T. et al: "SOCS-1 can suppress CD3ζ-and Syk-mediated NF-AT activation in a non-lymphoid cell line."FEBS Letters. 472. 235-240 (2000)
Matsuda, T. 等人:“SOCS-1 可以抑制非淋巴细胞系中 CD3δ 和 Syk 介导的 NF-AT 激活。”FEBS Letters 472. 235-240 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
韋星呈: "B細胞におけるマウスRAG2プロモータ制御機構の解析"第29回日本免疫学会総会・学術集会記録. 92-92 (1999)
魏星成:“B细胞中小鼠RAG2启动子控制机制的分析”日本免疫学会第29届年会论文集92-92(1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kishi,H.,Wei,X.-C.,Jin,Z.-X.,Fujishiro,Y.,Nagata,T.,Matsuda,T.and Muraguchi,A.: "Lineage-specific regulation of the murine RAG-2 promoter : GATA-3 in T cells and Pax-5 in B cells."Blood.. 95. 3845-3852 (2000)
Kishi,H.、Wei,X.-C.、Jin,Z.-X.、Fujishiro,Y.、Nagata,T.、Matsuda,T. 和 Muraguchi,A.:“小鼠 RAG 的谱系特异性调节
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MURAGUCHI Atsushi其他文献

TCR repertoire analysis of peptide-specific T cells using immunospot array assay on a chip (T-ISAAC) technology
使用芯片上免疫点阵列测定 (T-ISAAC) 技术对肽特异性 T 细胞进行 TCR 谱分析
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KOBAYASHI Eiji;MURAGUCHI Atsushi;KISHI Hiroyuki
  • 通讯作者:
    KISHI Hiroyuki
Development of a novel tumor antigen-specific TCR cloning system using a microarray chip
使用微阵列芯片开发新型肿瘤抗原特异性 TCR 克隆系统
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KOBAYASHI Eiji;OZAWA Tatsuhiko;HAMANA hiroshi;MURAGUCHI Atsushi;KISHI Hiroyuki
  • 通讯作者:
    KISHI Hiroyuki
Establishment of West Nile virus - neutralizing human monoclonal antibodies derived from the individuals vaccinated with inactivated Japanese encephalitis virus by ISAAC technology (2nd.)
通过ISAAC技术建立西尼罗河病毒-中和来自接种灭活日本脑炎病毒的个体的人单克隆抗体(第二次)
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    MASAKI Hideyuki;OZAWA Tatsuhiko;TAKASAKI Tomohiko;KISHI Hiroyuki;MURAGUCHI Atsushi
  • 通讯作者:
    MURAGUCHI Atsushi
A rapid and easy system providing cDNAs cloning of antigen specific TCRs from single human and mouse T-cells within 4 days
一种快速、简单的系统,可在 4 天内从单个人类和小鼠 T 细胞中克隆抗原特异性 TCR 的 cDNA
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    HAMANA Hiroshi;KISHI Hiroyuki;SHITAOKA Kiyomi;OZAWA Tatsuhiko;MURAGUCHI Atsushi
  • 通讯作者:
    MURAGUCHI Atsushi

MURAGUCHI Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MURAGUCHI Atsushi', 18)}}的其他基金

Development of an innovative lymphocyte chip to establish personalized immuno-therapy for infectious diseases
开发创新淋巴细胞芯片以建立传染病的个性化免疫治疗
  • 批准号:
    26293237
  • 财政年份:
    2014
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Challenge the infectious diseases and cancers using innovative array technology: Development of hTEC10
利用创新阵列技术挑战传染病和癌症:hTEC10的开发
  • 批准号:
    25670463
  • 财政年份:
    2013
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of personalized immunotherapy method for virus-infected diseases using lymphocyte chip
利用淋巴细胞芯片建立病毒感染性疾病个体化免疫治疗方法
  • 批准号:
    23390264
  • 财政年份:
    2011
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A new strategy for antibody-therapy against infectious diseases and bacterial terrorism using lymphocyte-chip
利用淋巴细胞芯片针对传染病和细菌恐怖主义进行抗体治疗的新策略
  • 批准号:
    20390286
  • 财政年份:
    2008
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of rapid production of human monoclonal antibodies against emerging infectious pathogens using lymphocyte chip
使用淋巴细胞芯片快速生产针对新出现的传染性病原体的人单克隆抗体的开发
  • 批准号:
    18390288
  • 财政年份:
    2006
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Efficient production of human recombinant antibodies against hepatitis virus using a novel micro-well array system
使用新型微孔阵列系统高效生产抗肝炎病毒的人重组抗体
  • 批准号:
    15390312
  • 财政年份:
    2003
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ANALYSIS OF TRANSCRIPTIONAL REGULATION OF RECOMBINATION ACTIVATING GENE (RAG) DURING PROCESS OF LYMOHOID DEVEROPMENT
重组激活基因(RAG)在淋巴样发育过程中的转录调控分析
  • 批准号:
    09836004
  • 财政年份:
    1997
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10031278
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10737781
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10468561
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10454909
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Supplement: Large scale single-cell gene rearrangement detection with a microfluidic device
补充:利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10522287
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Large scale single-cell gene rearrangement detection with a microfluidic device
利用微流控装置进行大规模单细胞基因重排检测
  • 批准号:
    10202529
  • 财政年份:
    2020
  • 资助金额:
    $ 8.58万
  • 项目类别:
Resistance to paclitaxel in triple negative breast cancer cells is associated with ABCB1 gene rearrangement
三阴性乳腺癌细胞对紫杉醇的耐药性与 ABCB1 基因重排有关
  • 批准号:
    315555
  • 财政年份:
    2014
  • 资助金额:
    $ 8.58万
  • 项目类别:
Elucidation of the epigenetic regulation of the antigen receptor gene rearrangement
阐明抗原受体基因重排的表观遗传调控
  • 批准号:
    17590246
  • 财政年份:
    2005
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
FISH analysis for EWSR1 gene rearrangement in Ewing sarcoma/PNET
尤文肉瘤/PNET 中 EWSR1 基因重排的 FISH 分析
  • 批准号:
    17590327
  • 财政年份:
    2005
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms of tumorigenesis and invasiveness of pancreatic cancer by gene rearrangement using immortalized pancreatic epithelial cells.
使用永生化胰腺上皮细胞进行基因重排,阐明胰腺癌的肿瘤发生和侵袭机制。
  • 批准号:
    14370386
  • 财政年份:
    2002
  • 资助金额:
    $ 8.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了